Drugs / Ferriderisomaltose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07523646 | May 2026 → Apr 2028 expected | anemia, infective endocarditis | Rigshospitalet, Denmark | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferriderisomaltose | “A one-time IV infusion of Ferriderisomaltose administered over 45-60 minutes.” NCT07523646 ↗ |
| Route | Intravenous | “A one-time IV infusion of Ferriderisomaltose administered over 45-60 minutes.” NCT07523646 ↗ |